S-3 S-3ASR EX-FILING FEES 0000885725 BOSTON SCIENTIFIC CORP 0000885725 2025-02-18 2025-02-18 0000885725 1 2025-02-18 2025-02-18 0000885725 2 2025-02-18 2025-02-18 0000885725 3 2025-02-18 2025-02-18 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

BOSTON SCIENTIFIC CORP

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Debt Senior Debt Securities 457(r) 0.0001531
Fees to be Paid 2 Debt Subordinated Debt Securities 457(r) 0.0001531
Fees to be Paid 3 Other Guarantees 457(r) 0.0001531
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 0.00

$ 0.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 0.00

Offering Note

1

(1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices.

2

(1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices.

3

(1) The debt securities may be issued by Boston Scientific Corporation or American Medical Systems Europe B.V. Debt securities issued by Boston Scientific Corporation may be guaranteed by American Medical Systems Europe B.V. Debt securities issued by American Medical Systems Europe B.V. may be guaranteed by Boston Scientific Corporation. No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required. (2) The registrants are relying on Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, to defer payment of all of the registration fee. In connection with the securities offered hereby, the registrants will pay "pay-as-you-go registration fees" in accordance with Rule 456(b). The registrants will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment. (3) An unspecified aggregate initial offering price and number of securities of each identified class is being registered and may from time to time be offered at unspecified prices.